Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

RomaniaBack to Romania

Clinical trials in Rosu

2 clinical trials in Rosu, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Rosu at a glance
2
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Rosu

Open in trial search

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Atrial fibrillation

Not yet recruiting

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Regn7508
  • Sponsor:Regeneron Pharmaceuticals Inc.

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Rosu

What the registry says about research in the country

01 Rosu
Cardiovascular Disease – Atrial Fibrillation
Research in Rosu is centered on a common heart rhythm disorder that raises the chance of serious vascular events. Evaluation of REGN7508 compared with standard anticoagulant therapy Combined REGN7508 and REGN9933 versus placebo Risk assessment of clinically relevant bleeding Stroke and systemic embolism prevention for patients unsuitable for oral anticoagulation The trials aim to expand treatment choices and lower the incidence of stroke and embolic complications in atrial fibrillation.
Anticoagulation Safety in Atrial Fibrillation
Ongoing studies examine how to protect patients from ischemic stroke while reducing the likelihood of major bleeding events. Comparison of bleeding risk between experimental agents and apixaban Evaluation of major bleeding outcomes with dual‑target therapy Analysis of stroke prevention effectiveness in high‑risk cohorts Safety profiling for participants unable to use conventional oral anticoagulants Findings are expected to inform safer anticoagulation strategies for individuals living with atrial fibrillation.
Back to RomaniaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.